The spectrum of kidney biopsy findings in HIV-infected patients in the modern era.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
05 2020
Historique:
received: 08 10 2019
revised: 27 11 2019
accepted: 03 01 2020
pubmed: 13 4 2020
medline: 22 6 2021
entrez: 13 4 2020
Statut: ppublish

Résumé

HIV-associated kidney disease is evolving rapidly. Few North American studies have addressed modern trends and none has applied the 2018 Kidney Disease Improving Global Outcomes (KDIGO) pathologic classification. Therefore we performed a retrospective clinical-pathologic analysis of all HIV-positive patients with kidney biopsy interpreted at Columbia University from 2010-2018 using the KDIGO classification. The biopsy cohort of 437 HIV-positive patients had median age 53 years, including 66% males, 80% on anti-retroviral therapy, 57% with hypertension, 31% with diabetes, 27% with hepatitis C and 6% with hepatitis B co-infections. Race, known in 308 patients, included 58% black, 25% white and 17% Hispanic. Pathologic diagnoses were surprisingly diverse. Immune complex glomerulonephritis (ICGN) and diabetic nephropathy each outnumbered HIV-associated nephropathy, followed by tenofovir nephrotoxicity, FSGS- not otherwise specified (NOS) and global sclerosis (NOS). HIV-associated nephropathy was the most common disease in patients not on anti-retroviral therapy, and 94% were black. The association of FSGS (NOS) with black race (68%) and anti-retroviral therapy use (77%) suggests some cases may represent attenuated HIV-associated nephropathy. The most common ICGNs were IgA nephropathy and membranous glomerulopathy, both associating with anti-retroviral therapy (over 90%), followed by hepatitis C-associated proliferative ICGN. Among the 16 cases of uncharacterized ICGN lacking identifiable etiology, 69% were not on anti-retroviral therapy, possibly representing true HIV-associated immune complex kidney disease. Dual diseases occurred in 17% of patients, underscoring lesion complexity. Thus, anti-retroviral therapy has shifted the landscape of HIV-associated kidney disease toward diverse ICGN, diabetic nephropathy, and non-collapsing glomerulosclerosis, but has not eradicated HIV-associated nephropathy.

Identifiants

pubmed: 32278618
pii: S0085-2538(20)30116-2
doi: 10.1016/j.kint.2020.01.018
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1006-1016

Subventions

Organisme : NIDDK NIH HHS
ID : P01 DK056492
Pays : United States

Informations de copyright

Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Satoru Kudose (S)

Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.

Dominick Santoriello (D)

Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.

Andrew S Bomback (AS)

Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA.

M Barry Stokes (MB)

Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.

Ibrahim Batal (I)

Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.

Glen S Markowitz (GS)

Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.

Christina M Wyatt (CM)

Department of Medicine, Division of Nephrology, Duke University School of Medicine, Durham, North Carolina, USA.

Vivette D D'Agati (VD)

Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA. Electronic address: vdd1@cumc.columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH